BogerLab
159 posts

BogerLab
@BogerLab
synthesis of biologically active natural products, development of new synthetic methods, heterocyclic chemistry, DNA-agent interactions, antitumor antibiotics
The Scripps Research Institute Katılım Mart 2012
338 Takip Edilen2.7K Takipçiler

@scrippsresearch @BogerLab The wild part @scrippsresearch is that Prof. Boger is basically in a race against evolution itself and might actually win. That's the kind of science fiction shit that keeps me believing humans can occasionally get it right.
English

“When it comes to antibiotic resistance, people aren’t looking for an alternative until there’s an urgent need for one.”
Scripps Research Prof. Dale Boger (@BogerLab) has developed a new molecule with the potential to protect against resistance for decades to come. To get the next-generation antibiotic into the hands of patients, however, will require external support for preclinical trials. More: ow.ly/5ths50YklTW

English
BogerLab retweetledi

Hey @Support @Safety @X,
Our lab account @BaranLabReads was suddenly suspended, but we have exciting science to share! Appeal was submitted can you please help?
Calling on our science collaborators & friends to please RT for visibility. @ScrippsResearch
English

BogerLab retweetledi

Prof. Jin-Quan Yu (@YulabJin) will receive the 5th Akira Suzuki Award for his research on C–H bond activation, which makes it easier to build complex molecules. His work accelerates advances in pharmaceuticals, molecular tools and materials science.
More: ow.ly/z0BL50WhOQf
English

@KUPharmacy A giant among giants. Rigorous application of (physical) organic chemistry to drug metabolism, deep scholarship, fabulous mentor, and kindest of gentleman. Best of the best and crushing loss for us all
English

KU Pharmacy regrets to share the passing of Emeritus Professor of Medicinal Chemistry Bob Hanzlik on March 28. His obituary is available at rumsey-yost.com/2025/03/robert… and his 2020 retirement message can be read at pharmacy.ku.edu/news/article/2….

English

Insights into Free Drug Release from Efficacious N-Acyl O-Aminophenol Duocarmycin Prodrugs | ACS Chemical Biology pubs.acs.org/doi/full/10.10…
Provocative observations made in wonderful collaborations that reveal an exclusive protein-mediated prodrug activation in cancer cells
English

@KUPharmacy Fantastic lectureship honoring a great scientist (Smissman) who championed the role and importance of Organic Chemistry in Medicinal Chemistry. So glad Ben will be among the list of speakers in this prestigious series!
English
BogerLab retweetledi

@saveantibiotics @koutterson An initiative that would bring big pharma back into the area would be to grant any company that successfully introduces a new antibiotic into the clinic be granted a 5 year extension on ANY one drug product they have in their portfolio. Every company would be very motivated
English

The current pipeline for new antibiotics is “on the verge of collapse,” @koutterson warns. globalhealthnow.org/2024-11/superb…
English

@Michael_A_Erb Cute as a button and so polite and poised for someone so young! Will melt your heart
English

After a half-day at school, my eldest just bumped into Reza Ghadiri, @BogerLab, and Ben Cravatt within the space of 5 min. His chemical education is complete.
English

@scrippsresearch @ScrippsGradPrgm @IanSeiple Thrilled and looking forward to your on campus arrival next month!
English

We’re pleased to welcome back @ScrippsGradPrgm alum @IanSeiple as a professor of chemistry. His work advances synthetic routes to complex molecules, like antibiotics to address antimicrobial resistance, and expands into cancer and aging research. More at: ow.ly/o4fp50TCz7O

English

@UKAMREnvoy @saveantibiotics @FlemingCentre @UKUN_NewYork @FCDOGovUK @UKgovGHS @Ara_Darzi Bring up the rumored, but great, proposal for truly incentivizing new antibiotic development: provide a company that introduces a new antibiotic into the clinic with an exclusive 5 yr extension to ANY product/patent in its portfolio (not just the antibiotic)
English








